US Edition
What Patients With Rheumatoid Arthritis Need to Know During Cancer
Summary by European Medical Journal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
JAK Inhibitors Could Increase Cancer Risks by as Much as 40%: Study
Older patients and those with high disease activity may face greater risks than others taking the common arthritis and autoimmune disease treatments. New research suggests that side effects of rheumatoid arthritis drugs like Xeljanz and Rinvoq may increase cancer risk by up to 40%. The findings were published by a team of German researchers in the Annals of R…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
